08048035968
Premium Exporter of Genuine REDITUX RA 500mg Injection from India to Singapore –Orchard|Phoenix Exim

1. General Information

Reditux RA 500 mg is a rituximab-based biologic medicine belonging to the monoclonal antibody class. Rituximab targets CD20-positive B cells, which play an important role in certain blood cancers and autoimmune diseases.

It is used under specialist medical supervision for conditions such as rheumatoid arthritis and certain hematological malignancies and autoimmune disorders. It should not be self-administered.

2. Product Information

  • Brand: Reditux RA 500 mg
  • Active ingredient: Rituximab
  • Strength: 500 mg
  • Dosage form: Concentrate for solution for infusion
  • Route: Intravenous (IV) infusion
  • Manufacturer: Dr. Reddy’s Laboratories Ltd.
  • Pack presentation: 500 mg in a 50 mL vial; pack configurations may vary.
  • Storage: Refrigerate at 2°C–8°C; do not freeze.
  • Prescription: Required
  • Administration: By a healthcare professional in an appropriate clinical setting.

3. Uses of Reditux RA 500 mg

Depending on the approved indication and the patient's medical condition, rituximab may be used for:

  • Rheumatoid arthritis (RA)
  • Non-Hodgkin lymphoma (NHL)
  • Chronic lymphocytic leukemia (CLL)
  • Granulomatosis with polyangiitis (GPA)
  • Microscopic polyangiitis (MPA)
  • Pemphigus vulgaris in appropriate approved settings

The exact indication, treatment combination and dosing schedule must be determined by the treating specialist.

4. Benefits of This Medicine

The potential therapeutic benefits of rituximab include:

  • Targets specific CD20-positive B cells.
  • Helps reduce abnormal B-cell activity involved in certain diseases.
  • Can be used in both oncology and autoimmune disease management.
  • May be used alone or alongside other medicines depending on the approved treatment protocol.
  • Provides a targeted biological approach compared with medicines that act broadly on the immune system.

Benefits vary between patients and depend on the condition being treated.

5. Side Effects

Reditux RA can cause side effects because rituximab affects B cells and the immune system. Important adverse reactions can include:

  • Infusion-related reactions
  • Fever and chills
  • Headache
  • Weakness or fatigue
  • Nausea
  • Skin rash or itching
  • Infections
  • Reduced blood-cell counts
  • Neutropenia
  • Reactivation of hepatitis B
  • Rare but serious infections and other severe reactions.

Serious reactions can occur during or after infusion, so medical monitoring is essential.

6. Common Side Effects

Some commonly reported effects include:

  • Headache
  • Weakness
  • Fever
  • Nausea
  • Rash
  • Itching
  • Infusion-related symptoms
  • Infections
  • Changes in blood-cell counts

If symptoms are severe, persistent or unusual, the patient should contact their healthcare provider promptly.

7. How to Use

Reditux RA 500 mg must be administered by a doctor or trained healthcare professional through IV infusion. It is not intended for self-injection.

The doctor determines:

  • The appropriate dose
  • Infusion schedule
  • Number of treatment cycles
  • Whether it should be combined with other medicines
  • Required premedication and monitoring

Patients may receive medicines such as antihistamines and/or corticosteroids before infusion to reduce the risk of infusion-related reactions, depending on the treatment protocol.

8. How Reditux RA Works

Reditux RA contains rituximab, a monoclonal antibody that binds to the CD20 antigen found on B cells. This helps eliminate or reduce targeted B cells through immune-mediated mechanisms.

Because B cells can contribute to certain blood cancers and autoimmune diseases, reducing these cells can help control the underlying disease process.

9. Safety Advice

Important safety considerations include:

  • Use only under specialist medical supervision.
  • Do not self-administer the medicine.
  • Screening for hepatitis B is important before treatment because reactivation can occur.
  • Patients should be monitored for infusion reactions.
  • Tell the doctor about previous infections and current medicines.
  • Blood counts may need regular monitoring.
  • Tell the doctor about heart or liver problems.
  • Discuss planned vaccinations with the treating doctor.
  • Active serious infections should be appropriately evaluated before treatment.
  • Rituximab can increase susceptibility to infections.
  • Store at 2°C–8°C and do not freeze.
  • Keep the medicine in its appropriate cold-chain conditions during transportation and storage.

10. Frequently Asked Questions (FAQs)

Q1. What is Reditux RA 500 mg?
Reditux RA 500 mg is a rituximab-containing monoclonal antibody medicine used for certain cancers and autoimmune conditions.

Q2. What is the active ingredient?
The active ingredient is rituximab 500 mg.

Q3. Is Reditux RA an injection or infusion?
It is supplied as a concentrate for intravenous infusion, which is administered by a healthcare professional.

Q4. Does Reditux RA require refrigeration?
Yes. It should generally be stored at 2°C–8°C and must not be frozen.

Q5. Can I administer Reditux RA at home?
No. It should be administered under appropriate medical supervision because serious infusion reactions can occur.

Q6. Is Reditux RA a prescription medicine?
Yes. It is a prescription medicine and should only be used according to a qualified healthcare professional's instructions.

Q7. What conditions can rituximab treat?
Depending on the approved indication, rituximab is used for conditions including NHL, CLL, rheumatoid arthritis, GPA and MPA, among others.

Q8. Does Reditux RA have side effects?
Yes. Infusion reactions, headache, fever, weakness, infections and blood-count changes are among the possible adverse effects.

Q9. What tests may be required before treatment?
Doctors may evaluate blood counts and screen for hepatitis B and other relevant infections before treatment.

Q10. Can Reditux RA be exported internationally?
International supply is subject to the prescription, import, registration and pharmaceutical regulations of the destination country. Exporters and buyers should verify applicable requirements before arranging shipment.

11. Substitute for Reditux RA 500 mg

Products containing the same active ingredient rituximab 500 mg may be considered alternatives, but substitution should be approved by the treating physician.

Examples reported as rituximab alternatives include:

  • Lupiximab 500 mg Injection – Lupin
  • Enfiera/Enfeira 500 mg – Zydus, depending on market and product availability.

A substitute should not be selected solely on the basis of price or availability, particularly for biologic medicines.

12. SEO Keywords

  • Reditux RA 500 mg Injection exporter from India
  • Reditux RA 500 mg supplier from India
  • Reditux RA 500 mg wholesale supplier
  • Rituximab 500 mg Injection exporter
  • Rituximab 500 mg supplier India
  • Reditux RA 500 mg pharmaceutical exporter
  • Reditux RA 500 mg injection supplier
  • Reditux RA 500 mg cold chain supplier
  • Reditux RA 500 mg for rheumatoid arthritis
  • Rituximab injection for rheumatoid arthritis
  • Rituximab 500 mg oncology medicine supplier
  • Reditux 500 mg injection exporter India
  • Reditux 500 mg injection manufacturer India
  • Genuine Reditux RA 500 mg supplier
  • Prescription rituximab 500 mg supplier
  • Reditux RA 500 mg export from Nagpur
  • Phoenix Exim Reditux RA supplier
  • Pharmaceutical exporter from Nagpur India
  • Oncology medicine exporter from India
  • Biologic medicine exporter India
  • Rituximab medicine exporter to USA
  • Rituximab medicine exporter to UK
  • Rituximab medicine exporter to Australia
  • Rituximab medicine exporter to Singapore
  • Rituximab medicine exporter to Canada
  • Rituximab medicine exporter to South Korea
  • Rituximab medicine exporter to UAE
  • Reditux RA 500 mg international pharmaceutical supplier
Aug 20th, 2026 3:35 PM

Keywords